Oak HC/FT brings in experienced pharma exec Adams as EIR

1226

Venture capital and growth equity investor Oak HC/FT has brought in experienced pharmacy industry exec Jenn Adams as an executive in residence.

Adams will be responsible for developing new tech-enabled healthcare businesses through a combination of building from scratch and investing in early and growth-stage companies.

She was most recently SVP and President, clinical product solutions for AmerisourceBergen, and prior to that served as president of PharMEDium.

Oak HC/FT co-founder and general partner Andrew Adams said, “Jenn is a distinguished leader in the healthcare community, and we’re proud to welcome her to our team.

“Her expertise and insights will significantly strengthen our ability to identify promising digital health companies and accelerate their path to success.”

Adams said, “I’m thrilled to join a team that shares my belief in the importance of providing value through patient centric solutions.

“The patient experience is an important driver for an improved healthcare system, and I look forward to working with the team at Oak HC/FT to build and invest in companies that enable a better experience.”

Other recent additions to Oak HC/FT’s team include fintech-focused EIR Michael Vaughan and principal Allen Miller.

The firm collected $600m for its second fund in 2017, to follow a $500m debut vehicle from three years before.

Oak looks to back healthcare and fintech businesses, and has previously targeted niches including high drug costs, treating patients with complex medical conditions, modernising payment systems and insurance frameworks, and reducing financial fraud and abuse, among others.

Copyright © 2019 AltAssets